Friday’s IPO slate — Aevex Corp. (AVEX), Alamar Biosciences (ALMR), and Kailera Therapeutics (KLRA) — delivered a constructive signal for the broader IPO market, with all three names opening at strong double-digit premiums to their respective IPO prices. As the first meaningful cluster of deals to come to market in recent weeks, the group sets an early tone for sentiment, with a growing pipeline behind it including Yesway Inc., National Healthcare Properties, The Elmet Group, and X-Energy Inc., all expected to trade the week of 4/20.
Aevex (AVEX) opened at $23.01 versus a $20.00 IPO price, representing a ~15% premium out of the gate and immediately confirming early demand with a Bull signal at the open. The stock quickly pulled back to establish its session low before stabilizing and building momentum into the afternoon, ultimately pushing to a high of $27.96 and closing near those levels. While a momentum-based risk signal developed earlier in the session, the ability to recover and finish near highs stood out as one of the stronger intraday performances of the group. With only one downside signal observed, the closing price effectively serves as a secondary reference point alongside that signal, providing a useful lens on how the early demand held up through the full session.
Alamar Biosciences (ALMR) opened at $22.60 compared to its $17.00 IPO price, a roughly ~33% premium that marked one of the stronger debuts of the day. Shares traded up toward the $24.50 area during the session but struggled to hold those gains, fading into the afternoon and briefly testing lows near $21.50. A Bull signal was triggered early, but two separate downside signals followed later in the day, reflecting a shift in intraday control as early strength gave way to more persistent selling pressure.
Kailera Therapeutics (KLRA) delivered the largest opening move, trading at $26.00 versus a $16.00 IPO price — a ~63% premium. Early trading saw a push toward $27.50 before the stock rotated lower and spent much of the session working through a range that extended down toward the mid-$23s. Unlike the other two names, KLRA did not generate a Bull signal at the open, and while it attempted to firm into the close around $26.16, the overall profile remained more rotational, with one downside signal marking the session.
Across all three names, one consistent theme emerged: momentum deterioration developed at some point during the trading day, even as early pricing strength was clearly present. In part, the magnitude of those opening premiums likely contributed to some early profit-taking, as participants took advantage of immediate gains. This dynamic — strong opens followed by less consistent follow-through — continues to define the current IPO backdrop.
Taken together, today’s group reinforces an increasingly familiar dynamic: strong IPO pricing and healthy opening premiums are beginning to re-emerge, signaling improving sentiment, but conviction remains selective beneath the surface. With a fuller calendar set to follow next week, the durability of this early demand will be tested quickly as more supply comes to market.